Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

M. Macerelli, C. Caramella, L. Faivre, B. Besse, D. Planchard, V. Polo, M. Ngo Camus, A. Celebic, V. Koubi-Pick, L. Lacroix, J. P. Pignon, J. C. Soria

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?'. Together they form a unique fingerprint.

Medicine & Life Sciences